AKR1B10 and hepatocellular carcinoma: Based on the findings reported to date, we speculate that AKR1B10-positive cells may interact with other factors, such as HCV/HBV viral load or presence of cirrhosis to activate or repress additional pathways, thereby contributing to a number of specific HCC subtypes with variable prognoses.